Reblozyl multiple strengths Images
Generic Name: luspatercept
This medication has been identified as Reblozyl multiple strengths. It is supplied by Celgene Corporation.
Reblozyl is used in the treatment of Myelodysplastic Syndrome; Beta Thalassemia; Anemia and belongs to the drug class miscellaneous erythropoiesis agents. Reblozyl multiple strengths is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Reblozyl
- Generic Name
- luspatercept
- Strength
- multiple strengths
- Availability
- Prescription only
- Drug Class
- Miscellaneous erythropoiesis agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celgene Corporation
- National Drug Code (NDC)
- multiple
See also:
Procrit
Procrit is a man-made protein used to treat anemia caused by chronic kidney disease, chemotherapy ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Vitamin B6
Vitamin B6 is used for anemia, dietary supplementation, drug induced vitamin/mineral deficiency ...
Epogen
Epogen is used to treat anemia (a lack of red blood cells in the body). Learn about side effects ...
Retacrit
Retacrit is used for anemia, anemia due to chronic kidney disease, anemia prior to surgery, anemia ...
Integra
Integra is used for anemia, vitamin/mineral supplementation and deficiency
Zynteglo
Zynteglo (betibeglogene autotemcel) is a gene therapy indicated for the treatment of patients with ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Fergon
Fergon is used for anemia due to chronic kidney disease, iron deficiency anemia, vitamin/mineral ...
More about Reblozyl (luspatercept)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous erythropoiesis agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.